Patient Reimbursement. Cestovní náhrady pacientům ' ' PSI shall reimburse reasonable travel expenses incurred by Study subjects, where applicable as per the Informed Consent Form and local regulations. PSI uhradí přiměřené cestovní výdaje vynaložené Subjektem hodnocení v oprávněných případech dle Informovaného souhlasu a lokálních předpisů. ' ' The total reimbursement amount for travel expenses is a fixed amount Cestovní výdaje budou hrazeny v pevné výši za jednu of per visit based on the completed Reimbursement log. If actual expenses exceed this amount, they will be compensated based on the relevant receipts provided upon Sponsor’s approval. ' PSI shall reimburse patients' for inconveniences incurred due to biopsy sampling, as per the Informed Consent Form. The total reimbursement amount is per a biopsy procedure. PSI shall návštěvu na základě vyplněného výkazu cestovních náhrad (Reimbursement log). V případě, že skutečné výdaje budou vyšší než uvedená fixní částka, bude náhrada poskytnuta se souhlasem zadavatele na základě předložení příslušných účtenek. ' ' ' Dle Informovaného souhlasu je PSI povinna nahradit pacientům nepohodlí spojené s podstoupením biopsie. Celková částka činí reimburse a fixed amount of colonoscopy visits. to the accompanying person for za jednu biopsii. PSI je povinna uhradit doprovodné osobě pacienta na návštěvu s kolonoskopií pevnou částku ve výši ' '.
Patient Reimbursement. Reimbursement covering subject travel costs, the loss of time and contribution for meals by the amount of 1500 CZK per each visit of subject at site and 300 CZK per each remote visit (regardless how many remote assessments will be completed during the visit) shall be provided to the subjects as fixed fee. Subjects will be given the option on how to be reimbursed for these costs, either by cash or via ClinCard. If the subject chooses ClinCard, the Study Staff will provide the subject with a ClinCard at their screening visit. If the subject chooses to be paid by cash, reimbursement to subjects will be paid through the financial accounting department at FN v Motole from advance payments in amount of 15 000,- CZK granted by Vertex for such purposes on the basis of the issue of an invoice (account details see paragraph 11 of this appendix 1). After the exhaustion of three quarters of the advanced payment, Health Service Provider is entitled to issue another invoice, in the amount agreed by both parties. Upon termination of the Study any advance payment balance will be returned to surplus account of Vertex within 60 days. Healthcare Service Provider shall maintain receipts of all payments made to subjects. All payments made to the subject will be monitored for verification. Vertex shall only pay for travel costs relating to visits required under the Protocol, subjects will not be reimbursed for travel costs related to visits which are made as part of their routine standard of care.
Patient Reimbursement. Trial Participants will receive reimbursement of travel expenses for exclusively Trial specific visits to the Institution in accordance with the IC form the Trial Participant has signed. Payments will be made by the Investigator/Institution directly to the Trial Participant and reimbursed by Sponsor or CRO upon receipt of an orderly documentation. The Institution will receive a deposit for reimbursement of travel expenses for Trial Participants in amount of VYMAZÁNO per patient/per completed Trial. Initial deposit will be provided for one Trial Participant. In case the provided deposit will not be spent for the patient reimbursement, it shall be returned, if not agreed otherwise. The subject reimbursement was approved by Ethics Committee as:
Patient Reimbursement. Sponsor agrees to pay for the cost of reasonable and customary medical treatment of any illness or injury sustained by a Study subject as a direct and sole result of the administration of the Study Device in accordance with the Protocol (except to the extent such costs are covered by the Study subject’s insurance or other third-party coverage); provided, however, that Sponsor’s obligations under this Section 6.3 shall not apply to the extent that any such costs or such illness or injury is attributable to: the failure of Principal Investigator, the Institution, any other Institution personnel, OSF or any other OSF personnel involved in the performance of the Study to adhere to the terms of the Study Protocol or any written or oral instructions (including, without limitation, package inserts, where appropriate) relative to the use of any product(s) used in the performance of the Study, or comply with applicable FDA or other governmental requirements; any negligent or wrongful act or omission, willful malfeasance or malpractice, of Principal Investigator, the Institution, any other Institution personnel, OSF or any other OSF personnel involved in the performance of the Study; the Study subject’s primary disease or any concurrent disease not directly and solely caused by the administration of the Study Device in accordance with the Protocol; and/or the Study subject’s failure to comply with written information, instructions, or warnings contained in the Informed Consent executed by such subject or communicated to the Study subject by any Study personnel. OSF shall provide prompt written notice, no later than ninety (90) days, to Sponsor of the Subject injury or a potential subject injury. Sponsor shall not reimburse OSF or any third party for any injury claims received or notice of potential injury claims received after ninety (90) days from the date of the subject injury. The compensation provided to Study-subjects in this Section 6.3 shall be the sole and exclusive form of compensation of any type provided by Sponsor to the Study subjects for injuries related to this Study.
Patient Reimbursement. Reimbursement covering subject travel costs, the loss of time and contribution for meals by the amount of 1200 CZK per each visit of subject at site shall be provided to the subjects. Healthcare Service Provider shall maintain receipts of all payments made to subjects. All payments made to the subject will be monitored for verification. Vertex shall only pay for travel costs relating to visits required under the Protocol, subjects will not be reimbursed for travel costs related to visits which are made as part of their routine standard of care. Reimbursement of travel expenses to subjects will be paid through the financial accounting department at FN v Motole from advance payments in amount of 46,800 CZK granted by Vertex for such purposes on the basis of the issue of an advance invoice (account details see paragraph 12 of this appendix). Upon termination of the Study any advance payment balance will be returned to surplus account of Vertex within 60 days.
Patient Reimbursement. Reimbursement covering subject travel costs, the loss of time and contribution for meals by the amount of 1200 CZK per each visit of subject at site and 300 CZK per each remote visit (regardless how many remote assessments will be completed during the visit) shall be provided to the subjects. Healthcare Service Provider shall maintain receipts of all payments made to subjects. All payments made to the subject will be monitored for verification. Vertex shall only pay for travel costs relating to visits required under the Protocol, subjects will not be reimbursed for travel costs related to visits which are made as part of their routine standard of care. Reimbursement of travel expenses to subjects will be paid through the financial accounting department at FN v Motole from advance payments in amount of 30 000,- CZK granted by Vertex for such purposes on the basis of the issue of an invoice (account details see paragraph 11 of this appendix 1). After the exhaustion of three quarters of the advanced payment, Health Service Provider is entitled to issue another invoice, in the amount agreed by both parties. Upon termination of the Study any advance payment balance will be returned to surplus account of Vertex within 60 days. 8. Independent Ethics Committees (“IECs”) Payments. IEC costs will be reimbursed on a pass- through basis upon receipt of invoice and a re not included in the attached Budget. Any subsequent re- submissions or renewals, upon approval by Xxxxxx, will be reimbursed upon receipt of a ppropriate documentation. připraví podklad k fakturaci za služby lékárny provedené ve studii, jež jsou uvedeny v této smlouvě, a zašle je ke schválení odpovědné osobě ve společnosti Vertex Xxxxx_xxxxxxxx@xxxx.xxx. Schválený podklad k fakturaci bude odpovědným zástupcem Vertexu zaslán do finanční účtárny FN v Motole (xxxxxxxxxx@xxxxxxx.xx). Na základě podkladu připraví finanční účtárna FN v Motole fakturu, kterou zašle Xxxxxxxxxx instrukcí uvedených v této smlouvě. Platba je splatná po dokončení činností spojených se zahájením studie a po předložení požadovaných dokladů s uvedením údajů o dokončení zahajovacích činností. Kromě plateb uvedených v této smlouvě a dodatcích ke smlouvě nejsou splatné žádné další platby, pokud je písemně neschválil Vertex. 7. Pacientské náhrady. Pacientům budou propláceny náhrady zahrnující cestovní výdaje, ztrátu času a příspěvek na stravování ve výši 1200 Kč za každou návštěvu pacienta v centru a 300 Kč za každou vzdálenou návštěvu (b...
Patient Reimbursement. Reimbursement covering subject travel costs, the loss of time and contribution for meals up to the amount of 1200 CZK per each visit of subject at site shall be provided to the subjects. Healthcare Service Provider shall maintain receipts of all payments made to subjects. All payments made to the subject will be monitored for verification. Vertex shall only pay for travel costs relating to visits required under the Protocol, subjects will not be reimbursed for travel costs related to visits which are made as part of their routine standard of care. 8. Independent Ethics Committees (“IECs”) Payments. IEC costs will be reimbursed on a pass-through basis upon receipt of invoice and are not included in the attached Budget. Any subsequent re-submissions or renewals, upon approval by Xxxxxx, will be reimbursed upon receipt of appropriate documentation. 9.
Patient Reimbursement. The trial coordinator will offer the patient a $25 gift certificate to thank her for participating. The patient will sign a receipt to confirm that she received the gift certificate.
